FDA Approval Status for Flurbiprofen ANDA074431 by New HeightsRx
The FDA has granted an Abbreviated New Drug Application (ANDA) approval status of 'AP' for Flurbiprofen submitted by New HeightsRx.
Asset / Drug
Drug and asset intelligence for Flurbiprofen with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.